BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  AstraZeneca Inks R&D Deal With Ramaswamy’s Roivant for Hush-Hush Indication

  Vivek Ramaswamy’s parent company, Roivant Sciences, inked a development deal with Astra.

  October 19, 2017

   · 

  3 min read

   · 

  Mark Terry
• Prenetics Of Hong Kong Raises $40 Million For Individual DNA Testing

  Prenetics Limited raised $40 million to expand its pan-Asia DNA testing service aimed at individuals.

  October 19, 2017

   · 

  1 min read
• 

  FDA

  Novartis Has Set a Tricky Precedent in Gene Therapy

  A look at how the gene therapy approvals may end up confusing payers, lawmakers, and the general public at a time when the industry desperately needs clarity.

  October 19, 2017

   · 

  5 min read

   · 

  Karl Thiel
• 

  Drug Development

  DURECT Stock Plunges as Pain Med Fails Phase III

  DURECT’s Posimir (SABER - Bupivacaine) for post-surgical pain failed its Phase III clinical trial.

  October 19, 2017

   · 

  2 min read

   · 

  Mark Terry
• BioMidwest

  Myriad’s GeneSight Shown to Statistically Significantly Improve Generalized Anxiety Disorder Treatment Response and Decrease Benzodiazepine Use

  The positive results were presented at the 25th World Congress of Psychiatric Genetics.

  October 19, 2017

   · 

  8 min read
• Business

  INSYS Therapeutics to Report Third Quarter 2017 Results on Nov. 2

  The third quarter 2017 financial results will release on Thursday, Nov. 2, before the U.S. financial markets open.

  October 19, 2017

   · 

  1 min read
• Drug Development

  Corbus Pharmaceuticals Reports Positive Topline Results From Phase 2 Study In Rare Autoimmune Disease Dermatomyositis

  Corbus Pharmaceuticals Holdings announced positive topline results from its 16-week Phase II study of safety and efficacy of anabasum in dermatomyositis (“DM”).

  October 19, 2017

   · 

  8 min read
• Biotech Bay

  Science Exchange Honored by Goldman Sachs for Entrepreneurship

  Goldman Sachs is recognizing Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange as one of the 100 Most Intriguing Entrepreneurs of 2017 at its Builders & Innovators Summit in Santa Barbara, California.

  October 19, 2017

   · 

  3 min read
• Business

  3D Signatures Announces Changes to Its Board of Directors and Audit Committee

  3D Signatures added Keith Cassidy to the Company’s board of directors and to the Company’s audit committee, effective immediately.

  October 19, 2017

   · 

  5 min read
• IDBS Takes Bioanalysis Informatics To The Cloud

  Today IDBS has announced the release of its next-generation bioanalytical informatics solution.

  October 19, 2017

   · 

  2 min read